14.05
price up icon0.00%   0.00
after-market Handel nachbörslich: 13.78 -0.27 -1.92%
loading

Celcuity Inc Aktie (CELC) Neueste Nachrichten

pulisher
Jul 23, 2025

What analysts say about Celcuity Inc. stockExceptional gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Celcuity Inc. Stock Analysis and ForecastSuperior investment outcomes - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Celcuity Inc. a good long term investmentFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Celcuity Inc. stock priceSuperior stock growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

why celcuity inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Celcuity Inc. stock price move sharplyFree Elite Traders Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Celcuity Inc. stock performs during market volatilityBreakout Momentum Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Celcuity Inc. stock attracts strong analyst attentionProven High Yield Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Celcuity receives U.S. patent for gedatolisib dosing regimen - Investing.com Australia

Jul 15, 2025
pulisher
Jul 14, 2025

How To Trade (CELC) - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity Soars 17.16% on New Patent for Breast Cancer Drug - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity Receives New Patent for Gedatolisib - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity receives U.S. patent for gedatolisib dosing regimen By Investing.com - Investing.com South Africa

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042 - The Manila Times

Jul 14, 2025
pulisher
Jul 11, 2025

Celcuity, Inc. (NASDAQ:CELC) Receives $28.40 Average Target Price from Analysts - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market - MSN

Jul 10, 2025
pulisher
Jul 09, 2025

Celcuity(CELC) Shares Soar 4.70% on Phase 2 Trial Success - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention - PentictonNow

Jul 08, 2025
pulisher
Jul 04, 2025

Learn to Evaluate (CELC) using the Charts - news.stocktradersdaily.com

Jul 04, 2025
pulisher
Jul 02, 2025

Stifel Initiates Celcuity(CELC.US) With Buy Rating, Announces Target Price $30 - 富途牛牛

Jul 02, 2025
pulisher
Jul 01, 2025

Celcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLC - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

Celcuity Announces Promising Phase 1 Gedatolisib Results - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Celcuity reports positive early data for gedatolisib in cancer trials By Investing.com - Investing.com UK

Jun 30, 2025
pulisher
Jun 30, 2025

New Clinical Data: Celcuity's Cancer Drug Achieves Breakthrough Results in Dual Phase Studies - Stock Titan

Jun 30, 2025
pulisher
Jun 24, 2025

Rhumbline Advisers Has $427,000 Stock Position in Celcuity, Inc. (NASDAQ:CELC) - Defense World

Jun 24, 2025
pulisher
Jun 16, 2025

Analysts Set Celcuity Inc. (NASDAQ:CELC) Price Target at $30.80 - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Stocks in play: Roots Corp. - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

(CELC) Trading Advice - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 11, 2025

Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Revista ADVFN

Jun 11, 2025
pulisher
Jun 10, 2025

Cisco Powers AI-Ready Data Centers, From Hyperscale to Enterprise - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Has $519,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Has $679,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Grows Position in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Citadel Advisors LLC Buys New Stake in HUHUTECH International Group Inc. (NASDAQ:HUHU) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Advisers LP Decreases Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 04, 2025
$23.63
price up icon 3.30%
$36.59
price up icon 1.58%
$103.52
price up icon 0.10%
$27.57
price down icon 1.54%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.65%
Kapitalisierung:     |  Volumen (24h):